SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹39 Cr | ₹30 Cr | ₹20 Cr | ₹9.63 Cr | ₹8.23 Cr |
What is the latest Short Term Loans and Advances ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹39 Cr |
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹9.63 Cr |
| Mar2022 | ₹8.23 Cr |
How is Short Term Loans and Advances of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹39 Cr | 32.01 | |
| Mar2025 | ₹30 Cr | 52.63 | |
| Mar2024 | ₹20 Cr | 103.46 | |
| Mar2023 | ₹9.63 Cr | 16.97 | |
| Mar2022 | ₹8.23 Cr | - | |
Compare Short Term Loans and Advances of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹2,253.2 Cr | 19.5% | 19.4% | 48.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 19.5% |
19.4% |
48.6% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses